Identity of the rapidly appearing purple intermediate of D-amino acid oxidase.

Identity of the rapidly appearing purple intermediate of D-amino acid oxidase. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Identity of the rapidly appearing purple intermediate of D-amino acid oxidase. Abstract Text:

K Lyagi,M Nishikimi,N Oishi,

Identity of the rapidly appearing purple intermediate of D-amino acid oxidase. Publishing Authors By Initials

K Lyagi,M Nishikimi,N Oishi,

For similar natural sciences: time: time factors research abstracts see: natural sciences: time: time factors research

PUBMED ID PMID:

MEDLINE DATE:

Identity of the rapidly appearing purple intermediate of D-amino acid oxidase. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of biochemistry

VOLUME: 72

Page Numbers: 1369-77

Journal Abbreviation: J. Biochem.

ISSN: 0021-924X

DAY: 19

MONTH: Dec

YEAR: 1972

Identity of the rapidly appearing purple intermediate of D-amino acid oxidase. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 376600

Identity of the rapidly appearing purple intermediate of D-amino acid oxidase. Keywords Mesh Terms:

KEYWORDS: Time Factors

MESH TERMS:

Chemical & Substance for Abstract: Identity of the rapidly appearing purple intermediate of D-amino acid oxidase. Information

Substance Name: D-Amino-Acid Oxidase

Registry Number: EC 1.4.3.3

Grant and Affiliation Information for Identity of the rapidly appearing purple intermediate of D-amino acid oxidase.

AFFILIATION:

Country: JAPAN

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Biochem

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Identity of the rapidly appearing purple intermediate of D-amino acid oxidase Related Publications

• Absorption and fluorescence spectra of riboflavin di- and tributyrate.
• Additional evidence for the liberation of substrate alpha-hydrogen prior to reduction of the coenzyme in D-amino acid oxidase reaction.
• Carbohydrate-binding properties of L-fucose, D-mannose-specific lectin (SFL 100-2) particles produced by Streptomyces sp.
• Characteristics of gabexate mesilate-induced cell injury in porcine aorta endothelial cells.
• Clinical Approaches to Minimize Rash Associated With EGFR Inhibitors.
• Combined treatment with L: -carnitine and a pan-caspase inhibitor effectively reverses amiodarone-induced injury in cultured human lung epithelial cells.
• Comparisons between the effects of isoniazid in a single daily dose and in divided daily doses.
• Depression treatment in a sample of 1,801 depressed older adults in primary care.
• Editorial.
• Effect of light on the purple complex of D-amino-acid oxidase.
• Enzyme-substrate complex of pancreatic lipase and its artificial substrates, riboflavin di- and tributyrate.
• Estimation of the area under the curve for mycophenolic acid in adult renal transplant patients with concomitant tacrolimus using a limited sampling strategy.
• Identity of the rapidly appearing purple intermediate of D-amino acid oxidase.
• Increased rates of intense nasopharyngeal bacterial colonization of Vietnamese children with radiological pneumonia.
• Initiation of breastfeeding within 120 minutes after birth is associated with breastfeeding at four months among Japanese women: A self-administered questionnaire survey.
• Involvement of both tumor necrosis factor-alpha-induced necrosis and p53-mediated caspase-dependent apoptosis in nephrotoxicity of cisplatin.
• Light-induced phase-shifting of the peripheral circadian oscillator in the hearts of food-deprived mice.
• Structure and function of D-amino acid oxidase. IX. Changes in the fluorescence polarization of FAD upon complex formation.
• Structure and function of D-amino acid oxidase. IV. Electrophoretic and ultracentrifugal approach to the monomer-dimer equilibrium.
• Structure and function of D-amino acid oxidase. VI. Relation between the quaternary structure and the catalytic activity.
• Synthesis of selenocysteine and selenomethionine derivatives from sulfur-containing amino acids.
• The pulmonary function tests and prognosis of chronic obstructive lung diseases.
• [Cineradiographical significance for diagnosis and treatment of thrombosed Björk-Shiley prosthesis in the aortic position]
• [Oncology pharmacy specialists in oncology.]
• [Open mitral commissurotomy (author's transl)]
• [Operative results of tricuspid valve replacement with St. Jude Medical prosthesis]
• [Prosthetic valve endocarditis indications of surgical treatment from analysis of 11 cases]
• [Selection of a prosthetic valve for mitral valve replacement]
• [Ten years experience with the St. Jude Medical valve prosthesis for mitral valve replacement]
• [Valvuloplasty in mitral valve insufficiency and the follow-up results]